NAFDAC warns of suspected counterfeit asthma medication found in Nigerian market
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the circulation of a suspected counterfeit asthma medicine, warning that its use could lead to treatment failure and other serious health risks.
The agency also encouraged the public to report suspected cases of counterfeit or substandard medicines to the nearest NAFDAC office via its toll-free line, email, or online reporting platforms.
The agency added that the suspected counterfeit product is labelled as being manufactured by Legency Remedies PVT Ltd, located in Himachal Pradesh, India.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
